Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRE Synchronous Chemotherapy for LAPC
NCT03673137Phase 3Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Sep 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in pancreatic adenocarcinoma (PDAC), sponsored by Fuda Cancer Hospital. Started Sep 2019; status: completed.
02
Drugs
gemcitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03673137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03673137.